世界中聯臨床用藥安全專業委員會《雷公藤多苷片治療慢性腎臟病安全用藥指南》立項通知
2022-03-24由 世界中醫藥學會聯合會 發表于 農業
雷公藤甙怎麼讀
世界中醫藥學會聯合會
世界中醫藥學會聯合會專業委員會標準
立項通知
WorldFederation of Chinese Medicine Societies
Announcementfor Specialty Committee Standards
世界中醫藥學會聯合會批准臨床用藥安全專業委員會提交的《雷公藤多苷片治療慢性腎臟病安全用藥指南》(SCM-C/NP 0190-2022)立項,現予通知。
The SCM-Cstandard (SCM-C/NP 0190-2022) of Guidelinefor safe use of Tripterygium Glycosides Tablets in chronic kidney diseaseproposed bySpecialtyCommittee of clinical drug safety research of WFCMS was initiated by WorldFederation of Chinese Medicine Societies and were now effective。
世界中醫藥學會聯合會
World Federation of Chinese MedicineSocieties
二〇二二年一月十七日
January 17th, 2022